Stocks in play: Body and Mind Inc
Reported its financial results for the second fiscal quarter ended January 31, 2022. Q2 FY2022 Financial Summary highlights in USD include a revenue of $8.05 million, a 27% increase over Q2 FY2021 revenue of $6.32 million, and a 6% increase over Q1 FY2022 revenue of $7.57 million USD, and a Q2 FY2022 Gross profit of $3.02 million; a 10% increase over Q2 FY2021 Gross profit of $2.75 million. Body and Mind Inc shares C.BAMM are trading down $0.05 at $0.22.
Read:
Reducing the Risks of Adverse Reactions to Covid Vaccines May Also Reduce Hesitancy and Injuries
Growing Plant-Based Protein Wholesalers Seizing Upon Market’s Appetite for Vegan Options
Therapy Shake-Up Called for by Mental Health Experts Seeking Solutions for Mental Health Crisis
Pharmacies and In-Clinic Testing Set to Remain as Covid-19 Numbers Shift into Post-Pandemic Phase
Biotech Innovators Making Strides Towards Meeting Increased Demand for Breast Cancer Treatments